FIGURE 1.
Flow diagram and study utilisation of the subjects enrolled in the study. CBD; chronic beryllium disease; BeS: beryllium sensitisation; ND-Con: beryllium-exposed nondiseased controls; NE-Con: nonexposed nondiseased controls; BeLPT: beryllium lymphocyte proliferation test.